↓ Skip to main content

Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not…

Overview of attention for article published in Trials, June 2020
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
634 Mendeley
Title
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol
Published in
Trials, June 2020
DOI 10.1186/s13063-020-04475-z
Pubmed ID
Authors

Marco Marietta, Paola Vandelli, Pasquale Mighali, Roberto Vicini, Valeria Coluccio, Roberto D’Amico, Daniela Aschieri, Lucio Brugioni, Enrico Clini, Mauro Codeluppi, Davide Imberti, Andrea Magnacavallo, Marianna Meschiari, Cristina Mussini, Sergio Orlando, Giovanni Pinelli, Antonello Pietrangelo, Luca Sarti, Matteo Silva

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 634 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 634 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 82 13%
Researcher 65 10%
Student > Master 60 9%
Other 50 8%
Student > Ph. D. Student 32 5%
Other 120 19%
Unknown 225 35%
Readers by discipline Count As %
Medicine and Dentistry 203 32%
Nursing and Health Professions 47 7%
Psychology 21 3%
Pharmacology, Toxicology and Pharmaceutical Science 21 3%
Biochemistry, Genetics and Molecular Biology 13 2%
Other 66 10%
Unknown 263 41%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2020.
All research outputs
#18,134,581
of 20,449,646 outputs
Outputs from Trials
#4,683
of 5,273 outputs
Outputs of similar age
#263,497
of 309,381 outputs
Outputs of similar age from Trials
#1
of 1 outputs
Altmetric has tracked 20,449,646 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,273 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,381 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them